- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Bausch & Lomb Inc. (BOL)
by latest | most commented
-
Bausch & Lomb Shareholders to Vote on Warburg Bid
-
Bausch & Lomb: Activist Investor Loeb Discloses a 9% Passive Stake
-
Loeb's Third Point Issues Latest 13F: Summary of Holdings
-
Warburg Pincus: A Potential Private Equity Vision Care Powerhouse
-
Stocks With the Least Analyst Love
-
ValueAct Capital Opposes Advanced Medical Optics' Bid For Bausch & Lomb
-
Bausch & Lomb: SAC Capital/Steven A. Cohen Discloses 5.5% Stake
-
Advanced Medical Optics Tops Warburg Pincus's Bid for Bausch & Lomb
-
End of Quarter Window Dressing: Top Stocks Should Continue To Perform Well
-
Bausch & Lomb Posts Q1 Profit Miss
-
Advanced Medical Optics Considering Offer for Bausch & Lomb
-
Biotech Buyout Frenzy Continues
-
Death of Public Companies? Oh, Please!
-
Goldman: Higher Bid for Bausch & Lomb Unlikely; Johnson & Johnson, Alcon Rally
-
Bausch & Lomb To Be Taken Private for $4.5B; Traders Anticipate Higher Bids
-
Bausch & Lomb Could Be Heading Toward a Buyout, But Based On What?
-
Vanguard Health Care Fund's Edward Owens: Buys, Sells, Portfolio
-
Fisher's Buyout Candidates
-
Bausch & Lomb's Early Dividend Announcement Unfair To Investors
-
Rob Black's Healthcare Stock Report
-
Bausch & Lomb: Overblown Concerns, Cheap Stock (BOL)
-
Johnson & Johnson's Acuvue to Profit from Bausch & Lomb's Troubles? (JNJ)
-
Is Bausch & Lomb's Distress an Opportunity for Investors? (BOL)
-
Bausch & Lomb: In The Eye Of The Storm (BOL)
-
Who Gains, Who Loses From the Bausch & Lomb Recall? (BOL, JNJ, COO, ACL, AGN, EYE, CTAC)
-
Bausch & Lomb's Fungus Woes (BOL)